Coronavirus disease 2019(COVID-19)is an acute respiratory illness caused by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2).COVID-19 pandemic has an unprecedented impact on economy,trade and human lifestyl...Coronavirus disease 2019(COVID-19)is an acute respiratory illness caused by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2).COVID-19 pandemic has an unprecedented impact on economy,trade and human lifestyle globally.Since the emergence of of SARS-CoV-2,more than 266 million infections and 5260888 deaths were reported globally over the last two years[1].The scientific achievements particularly in last two years yielded effective vaccines against COVID-19.A variety of platform technologies including protein subunit,viral vector,RNA,inactivated and DNA are being employed to develop effective vaccines.To date,vaccines that have been approved against COVID-19 include the Pfizer BioNTech(mRNA vaccine),Oxford-AstraZeneca(viral vector vaccine),Moderna(mRNA vaccine),Janssen Ad26.COV2.S(viral vector),Sinopharm,Sinovac-CoronaVac,Bharat Biotech’s Covaxin(inactivated virus vaccines),etc.As of December 2021,over 8 billion doses of COVID-19 vaccines have been administered globally[1].The details on the number of COVID-19 confirmed cases and global vaccination coverage are provided in Figure 1.展开更多
The frequent outbreaks of zoonotic infectious diseases present significant public health risk.Several viral diseases with epidemic potential are threatening global health security.Zoonotic viruses,in particular,have c...The frequent outbreaks of zoonotic infectious diseases present significant public health risk.Several viral diseases with epidemic potential are threatening global health security.Zoonotic viruses,in particular,have caused numerous epidemics in the recent years,resulting in high morbidity and mortality.The COVID-19 pandemic proved that any virus outbreak that can transmit human-to-human or with cross-species transmission capability could pose significant risk and contribute to a global pandemic.Several countries have not fully recovered from the COVID-19 crisis yet.展开更多
基金National Vaccine Institute, Thailand and Baiya Phytopharm Co., Ltd., Thailand for financial supportThe Second Century Fund (C2F), Chulalongkorn University for the doctoral fellowship
文摘Coronavirus disease 2019(COVID-19)is an acute respiratory illness caused by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2).COVID-19 pandemic has an unprecedented impact on economy,trade and human lifestyle globally.Since the emergence of of SARS-CoV-2,more than 266 million infections and 5260888 deaths were reported globally over the last two years[1].The scientific achievements particularly in last two years yielded effective vaccines against COVID-19.A variety of platform technologies including protein subunit,viral vector,RNA,inactivated and DNA are being employed to develop effective vaccines.To date,vaccines that have been approved against COVID-19 include the Pfizer BioNTech(mRNA vaccine),Oxford-AstraZeneca(viral vector vaccine),Moderna(mRNA vaccine),Janssen Ad26.COV2.S(viral vector),Sinopharm,Sinovac-CoronaVac,Bharat Biotech’s Covaxin(inactivated virus vaccines),etc.As of December 2021,over 8 billion doses of COVID-19 vaccines have been administered globally[1].The details on the number of COVID-19 confirmed cases and global vaccination coverage are provided in Figure 1.
基金financially supported by Baiya Phytopharm Co.,Ltd.One of the authors is supported by the Second Century Fund(C2F),Chulalongkorn University for the doctoral fellowship.
文摘The frequent outbreaks of zoonotic infectious diseases present significant public health risk.Several viral diseases with epidemic potential are threatening global health security.Zoonotic viruses,in particular,have caused numerous epidemics in the recent years,resulting in high morbidity and mortality.The COVID-19 pandemic proved that any virus outbreak that can transmit human-to-human or with cross-species transmission capability could pose significant risk and contribute to a global pandemic.Several countries have not fully recovered from the COVID-19 crisis yet.
